Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
Alzheimer'S Research & Therapy
|
December 6, 2014
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease
Eva Kontsekova, Norbert Zilka, Branislav Kovacech, et al.
Biochemical Society Transactions
|
July 24, 2012
The self-perpetuating tau truncation circle
Norbert Zilka, Branislav Kovacech, Peter Barath, et al.
Alzheimer'S Research & Therapy
|
December 6, 2014
First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model
Eva Kontsekova, Norbert Zilka, Branislav Kovacech, et al.
Acta Veterinaria Scandinavica
|
March 2, 2016
Risk factors for canine cognitive dysfunction syndrome in Slovakia
Stanislav Katina, Jana Farbakova, Aladar Madari, et al.
Brain Research
|
December 16, 2006
Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats
Miroslava Hrnkova, Norbert Zilka, Zuzana Minichova, et al.
Acta Neuropathologica
|
April 10, 2010
CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy
Norbert Zilka, Miroslava Korenova, Branislav Kovacech, et al.
Journal of Alzheimer'S Disease : JAD
|
September 15, 2009
Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier
Andrej Kovac, Monika Zilkova, Maria A Deli, et al.
Journal of Neuroinflammation
|
October 13, 2010
Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease
Zuzana Stozicka, Norbert Zilka, Petr Novak, et al.
Journal of Neurochemistry
|
January 15, 2009
Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
Jozef Hanes, Norbert Zilka, Miriam Bartkova, et al.
Neuroreport
|
January 25, 2003
DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope
Lubica Vechterova, Eva Kontsekova, Norbert Zilka, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
Alzheimer'S Research & Therapy
|
December 6, 2014
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease
Eva Kontsekova, Norbert Zilka, Branislav Kovacech, et al.
Biochemical Society Transactions
|
July 24, 2012
The self-perpetuating tau truncation circle
Norbert Zilka, Branislav Kovacech, Peter Barath, et al.
Alzheimer'S Research & Therapy
|
December 6, 2014
First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model
Eva Kontsekova, Norbert Zilka, Branislav Kovacech, et al.
Acta Veterinaria Scandinavica
|
March 2, 2016
Risk factors for canine cognitive dysfunction syndrome in Slovakia
Stanislav Katina, Jana Farbakova, Aladar Madari, et al.
Brain Research
|
December 16, 2006
Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats
Miroslava Hrnkova, Norbert Zilka, Zuzana Minichova, et al.
Acta Neuropathologica
|
April 10, 2010
CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy
Norbert Zilka, Miroslava Korenova, Branislav Kovacech, et al.
Journal of Alzheimer'S Disease : JAD
|
September 15, 2009
Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier
Andrej Kovac, Monika Zilkova, Maria A Deli, et al.
Journal of Neuroinflammation
|
October 13, 2010
Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease
Zuzana Stozicka, Norbert Zilka, Petr Novak, et al.
Journal of Neurochemistry
|
January 15, 2009
Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
Jozef Hanes, Norbert Zilka, Miriam Bartkova, et al.
Neuroreport
|
January 25, 2003
DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope
Lubica Vechterova, Eva Kontsekova, Norbert Zilka, et al.
Page
of 8